Clinical outcomes of the resolute zotarolimus-eluting stent in patients with in-stent restenosis: 2-year results from a pooled analysis

JACC: Cardiovascular Interventions

Volumn 6, Issue 9, 2013, Pages 905-913

  Richardt, Gert ^a   Leschke, Matthias ^b   Abdel Wahab, Mohamed ^a   Toelg, Ralph ^a   El Mawardy, Mohamed ^a   Serruys, Patrick W ^c   Silber, Sigmund ^d   Windecker, Stephan ^e   Belardi, Jorge A ^f   Neumann, Franz Josef ^g   Widimsky, Petr ^h  

^a Segeberger Kliniken GmbH   (Germany)

^b Kliniken Esslingen Department of Neurology   (Germany)

^c ERASMUS MEDICAL CENTER   (Netherlands)

^d Heart Center at the Isar   (Germany)

^e UNIVERSITY OF BERN   (Switzerland)

^f INSTITUTO CARDIOVASCULAR DE BUENOS AIRES   (Argentina)

^g UNIVERSITY HEART CENTER FREIBURG BAD KROZINGEN   (Germany)

^h CHARLES UNIVERSITY   (Czech Republic)

Author keywords

clinical outcome; in stent restenosis; PCI; zotarolimus eluting stent

Indexed keywords

EVEROLIMUS; R ZES; UNCLASSIFIED DRUG; ZOTAROLIMUS;

ADULT; AGED; ARTICLE; BARE METAL STENT; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DRUG ELUTING STENT; FEMALE; HEART DEATH; HEART INFARCTION; HUMAN; IN-STENT RESTENOSIS; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REGISTER; REVASCULARIZATION; STENT THROMBOSIS; TREATMENT FAILURE;

BARE-METAL STENT(S); BMS; CARDIAC DEATH; CD; CLINICAL OUTCOME; DES; DRUG-ELUTING STENT(S); IN-STENT RESTENOSIS; ISR; MI; MYOCARDIAL INFARCTION; PCI; PERCUTANEOUS CORONARY INTERVENTION; R-ZES; RESOLUTE ZOTAROLIMUS-ELUTING STENT(S); ST; STENT THROMBOSIS; TARGET LESION FAILURE; TARGET LESION REVASCULARIZATION; TARGET VESSEL MYOCARDIAL INFARCTION; TARGET VESSEL REVASCULARIZATION; TLF; TLR; TVMI; TVR; ZOTAROLIMUS-ELUTING STENT;

AGED; CARDIOVASCULAR AGENTS; CORONARY RESTENOSIS; CORONARY THROMBOSIS; DRUG-ELUTING STENTS; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; ODDS RATIO; PERCUTANEOUS CORONARY INTERVENTION; PROPENSITY SCORE; PROSTHESIS DESIGN; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REGISTRIES; RISK FACTORS; SIROLIMUS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84884412312     PISSN: 19368798     EISSN: 18767605     Source Type: Journal    
DOI: 10.1016/j.jcin.2013.04.017     Document Type: Article

References (30)

1. A. Kastrati, J. Mehilli, and N. von Beckerath Sirolimus-eluting stent or paclitaxel-eluting stent vs balloon angioplasty for prevention of recurrences in patients with coronary in-stent restenosis: a randomized controlled trial JAMA 293 2005 165 171
2. T. Koizumi, P.J. Fitzgerald, and Y. Honda Vascular responses to the multiple overlapped paclitaxel-eluting stents for the treatment of bare-metal in-stent restenotic lesions: angiographic and intravascular ultrasound analysis from the TAXUS-V ISR trial Cardiovasc Revasc Med 11 2010 140 148
3. D.H. Steinberg, M.A. Gaglia Jr., and T.L. Pinto Slottow Outcome differences with the use of drug-eluting stents for the treatment of in-stent restenosis of bare-metal stents versus drug-eluting stents Am J Cardiol 103 2009 491 495
4. J. Mehilli, R.A. Byrne, and K. Tiroch Randomized trial of paclitaxel- versus sirolimus-eluting stents for treatment of coronary restenosis in sirolimus-eluting stents: the ISAR-DESIRE 2 (Intracoronary Stenting and Angiographic Results: Drug Eluting Stents for In-Stent Restenosis 2) study J Am Coll Cardiol 55 2010 2710 2716
5. M. Unverdorben, C. Vallbracht, and B. Cremers Paclitaxel-coated balloon catheter versus paclitaxel-coated stent for the treatment of coronary in-stent restenosis. (PEPCAD II ISR) Circulation 119 2009 2986 2994
6. H. Rittger, J. Brachmann, and A.M. Sinha A randomized, multicenter, single-blinded trial comparing paclitaxel-coated balloon angioplasty with plain balloon angioplasty in drug-eluting stent restenosis: the PEPCAD-DES study J Am Coll Cardiol 59 2012 1377 1382
7. B. Scheller, C. Hehrlein, and W. Bocksch Treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter N Engl J Med 355 2006 2113 2124
8. B. Scheller, C. Hehrlein, and W. Bocksch Two year follow-up after treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter. (PACCOCATH ISR II) Clin Res Cardiol 97 2008 773 781
9. B. Scheller, Y.P. Clever, and B. Kelsch Long-term follow-up after treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter J Am Coll Cardiol Intv 5 2012 323 330
10. C. Hehrlein, G. Richardt, and M. Wiemer Description of Pantera Lux paclitaxel-releasing balloon and preliminary quantitative coronary angiography (QCA) results at six months in patients with coronary in-stent restenosis EuroIntervention 7 Suppl K 2011 K119 K124
11. R. Tölg, A. Erglis, and G. Richardt Paclitaxel releasing balloon with an inert BTHC excipient: six-month results on 1063 patients of the international DELUX registry Abstract EuroIntervention 8 Supplement N76 2012
12. A.C. Yeung, M.B. Leon, A. Jain for the RESOLUTE US Investigators Clinical evaluation of the Resolute zotarolimus-eluting coronary stent system in the treatment of de novo lesions in native coronary arteries: the RESOLUTE US clinical trial J Am Coll Cardiol 57 2011 1778 1783
13. I.T. Meredith, S.G. Worthley, and R. Whitbourn Long-term clinical outcomes with the next generation Resolute Stent System: a report of the two-year follow-up from the RESOLUTE clinical trial EuroIntervention 5 2010 692 697
14. P.W. Serruys, S. Silber, and S. Garg Comparison of zotarolimus-eluting and everolimus-eluting coronary stents N Engl J Med 363 2010 136 146
15. C. von Birgelen, M.W. Basalus, and K. Tandjung A randomized controlled trial in second-generation zotarolimus-eluting resolute stents versus everolimus-eluting Xience V stents in real-world patients. The TWENTE trial J Am Coll Cardiol 59 2012 1350 1361
16. Y.G. Lu, Y.M. Chen, L. Li, R.Z. Zhao, C.H. Fu, and H. Yan Drug-eluting stents vs. intracoronary brachytherapy for in-stent restenosis: a meta-analysis Clin Cardiol 34 2011 344 351
17. T.M. Schiele, J. Herbst, and B. Pöllinger Late and very late catch-up after 90Sr/90Y beta-irradiation for the treatment of coronary in-stent restenosis Acute Card Care 13 2011 9 13
18. F.-Z. Neumann, P. Widimsky, and J.A. Bleardi One-year outcomes of patients with the zotarolimus-eluting coronary stent: RESOLUTE International Registry EuroIntervention 7 2012 1181 1188
19. M. Abdel-Wahab, C.A. Nienaber, and A.E. Mostafa Clinical outcome of percutaneous treatment of in-stent restenosis with drug-eluting stents: results from the first phase of the prospective multicentre German (DES.DE) registry EuroIntervention 7 2011 201 208
20. R. Zahn, C.W. Hamm, and S. Schneider Incidence and predictors of target vessel revascularization and clinical event rates of the sirolimus-eluting coronary stent (results from the prospective multicenter German Cypher Stent Registry) Am J Cardiol 95 2005 1302 1308
21. R. Zahn, F.J. Neumann, and H.J. Büttner Long-term follow-up after coronary stenting with the sirolimus-eluting stent in clinical practice: results from the prospective multi-center German Cypher Stent Registry Clin Res Cardiol 101 2012 709 716
22. A.A. Khattab, C.W. Hamm, and J. Senges Incidence and predictors of target vessel revascularization after sirolimus-eluting stent treatment for proximal left anterior descending artery stenoses among 2274 patients from the prospective multicenter German Cypher Stent Registry Clin Res Cardiol 96 2007 279 284
23. D.H. Steinberg, T.L. Pinto Slottow, and A.N. Buch Impact of in-stent restenosis on death and myocardial infarction Am J Cardiol 100 2007 1109 1113
24. S. Rathore, Y. Kinoshita, and M. Terashima A comparison of clinical presentations, angiographic patterns and outcomes of in-stent restenosis between bare metal stents and drug eluting stents EuroIntervention 5 2010 841 846
25. Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS); European Association for Percutaneous Cardiovascular Interventions (EAPCI) W. Wijns, P. Kolh, and N. Danchin Guidelines on myocardial revascularization Eur Heart J 31 2010 2501 2555
26. G.N. Levine, E.R. Bates, and J.C. Blankenship 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions J Am Coll Cardiol 58 2011 e44-122
27. D.R. Holmes Jr., P. Teirstein, and L. Satler Sirolimus-eluting stents vs vascular brachytherapy for in-stent restenosis within bare-metal stents: the SISR randomized trial JAMA 295 2006 1264 1273
28. F. Alfonso, M.J. Pérez-Vizcayno, and R. Hernandez A randomized comparison of sirolimus-eluting stent with balloon angioplasty in patients with in-stent restenosis: results of the Restenosis Intrastent: Balloon Angioplasty Versus Elective Sirolimus-Eluting Stenting (RIBS-II) trial J Am Coll Cardiol 47 2006 2152 2160
29. G.W. Stone, S.G. Ellis, and C.D. O'Shaughnessy Paclitaxel-eluting stents vs vascular brachytherapy for in-stent restenosis within bare-metal stents: the TAXUS V ISR randomized trial JAMA 295 2006 1253 1263
30. I.M. Singh, S.J. Filby, and F.E. Sakr Clinical outcomes of drug-eluting versus bare-metal in-stent restenosis Catheter Cardiovasc Interv 75 2010 338 342